恆指公司公佈指數檢討結果,樂享集團(6988.HK)維持港股通資格
格隆匯8月20日丨恆生指數有限公司公佈截至2021年6月30日的恆生指數系列檢討結果,並將於2021年9月6日(星期一)起生效,同時港股通名單也會相應發生變動。根據本次檢討結果,樂享集團(6988.HK)將繼續維持恆生小型股指數和深港通標的資格。樂享集團是國內領先的新媒體效果營銷科技公司。公開資料顯示,樂享集團於2020年9月23日在港交所上市,並於2021年3月15日正式納入恆生綜合小型股指數,上市不到半年即獲納入港股通名單。公司已於7月30日刊發正面盈利預吿,並預計將於8月末公佈上半年業績。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.